- Browse by Author
Browsing by Author "Reisinger, Debra L."
Now showing 1 - 2 of 2
Results Per Page
Sort Options
Item Provider and Caregiver Satisfaction with Telehealth Evaluation of Autism Spectrum Disorder in Young Children During the COVID-19 Pandemic(Springer, 2022) Reisinger, Debra L.; Hines, Elesia; Raches, Christine; Tang, Qing; James, Cristina; Keehn, Rebecca McNally; Pediatrics, School of MedicineThe present study examines provider and caregiver satisfaction with telehealth evaluation of autism spectrum disorder (ASD) in young children during the coronavirus SARS-CoV-2 (COVID-19) pandemic. A telehealth model of ASD evaluation was implemented with 308 children ages 14 to 78 months between May 2020 to June 2021. Data were gathered from electronic health records, autism-specific telehealth diagnostic tools, and post-evaluation surveys. Overall, the majority of providers and caregivers were satisfied with telehealth ASD evaluation. Multiple variables were associated with ratings of satisfaction, differing by providers and caregivers. Findings have important implications for the feasibility and acceptability of telehealth ASD evaluations, in addition to key factors to consider in optimizing and sustaining telehealth evaluations beyond the COVID-19 pandemic.Item Regulating Together: Emotion Dysregulation Group Treatment for ASD Youth and Their Caregivers(Springer Nature, 2023) Shaffer, Rebecca C.; Schmitt, Lauren M.; Reisinger, Debra L.; Coffman, Marika; Horn, Paul; Goodwin, Matthew S.; Mazefsky, Carla; Randall, Shelley; Erickson, Craig; Pediatrics, School of MedicineIndividuals with autism spectrum disorder (ASD) experience behavioral and emotional symptoms hypothesized to arise from emotion dysregulation (ED), difficulty modulating emotional experience, expression, and intensity in an acceptable and contextually appropriate manner. We developed Regulating Together (RT)—an intensive-outpatient, caregiver-assisted group program to meet the ASD + ED intervention critical need. A within-subjects trial was conducted (5-week-control lead-in period, 5-week-treatment, and 5-and 10-weeks-post-treatment follow-ups). Forty-four youth with ASD + ED (25 8–12, 19 13–18 yr-olds, 88% male, mean FSIQ of 96) participated. Improvements were found in reactivity, emotion regulation knowledge, and flexibility post-treatment and 10-weeks post-treatment. A reduction in inpatient hospitalization rates by 16% from the 12 months pre-RT to 12 months post-RT was observed. RT shows promise to reduce ED in ASD.